About HemaBlock

HemaBlock Hemostatic Powder originates from over a decade of research and clinical use in the human market.  Since 2001, Medafor’s patented Microporous Polysaccharide Hemosphere (MPH) technology has been saving lives in both humans and animals- clinically proven to be a superior method to control surgical and topical hemorrhage in over 2 million human applications. Before the MPH technology was introduced into the Human surgical market it was private labeled by Medafor to Abbott Labs in 2001. While it became highly acclaimed in veterinary applications it was removed from this market in order for Medafor to focus on penetrating human sur...

Read More


CVC 2015
28 Aug 2015

CVC 2015

Central Veterinary Conference August 28th-31st Kansas City, MO
WVC 2015
15 Feb 2015

WVC 2015

Western Veterinary Conference  February 15th-19th Las Vegas, NV
NAVC 2015
17 Jan 2015

NAVC 2015

North American Veterinary Conference January 17-21, Orlando, FL

Sample Request

HemaBlock in Action: Testimonials & Case Reports

PowerPoint Presentation